Pluristem Therapeutics Inc.
PSTI · NASDAQ
6/30/2025 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -57.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49% | – | 100% | 96.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,746.2% | – | -119,069.6% | -62,166.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,740.3% | – | -126,747.8% | -65,383.3% |
| EPS Diluted | -3.56 | -1.77 | -1.6 | -2.86 |
| % Growth | -101.1% | -10.6% | 44.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |